Yan V. Wang

发表

Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab plus chemotherapy for platinum-resistant recurrent ovarian cancer.

P. Vuylsteke, E. Pujade-Lauraine, A. Husain, 2016, Gynecologic oncology.

Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T‐cell lymphoma: A randomized, controlled, open‐label, multicenter study

Mingzhi Zhang, Guan-nan Wang, Jiaqin Yan, 2020 .

Final analysis of overall survival in OCEANS, a randomized phase III trial of gemcitabine, carboplatin, and bevacizumab followed by bevacizumab until disease progression in patients with platinum-sensitive recurrent ovarian cancer

Yulei N. Wang, B. Goff, C. Aghajanian, 2014 .

Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial

L. Kong, L. Shen, Y. Shu, 2022, BMJ.

Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer.

B. Goff, C. Aghajanian, S. Blank, 2015, Gynecologic oncology.

Clinical efficacy of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) in the initial treatment of advanced stage (stage III–IV) extranodal NK/T-cell lymphoma, and its correlation with Epstein-Barr virus

Mingzhi Zhang, Lei Zhang, Y. Chang, 2019, Cancer management and research.

CMAR_A_191929 3555..3564

Mingzhi Zhang, Lei Zhang, Y. Chang, 2019 .

Efficacy of epidermal growth factor receptor inhibitors in combination with chemotherapy in advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials

Minghui Zhang, Yan Wang, Jiawei Yu, 2016, Oncotarget.

Clinical study on concurrent chemoradiotherapy combined with Kanglaite injection in the treatment of regionally advanced unresectable non-small cell lung cancer

Jianbo Ma, Xiaojun Qiu, B. Ji, 2007 .

Independent radiologic review: bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer.

Yan Wang, B. Goff, C. Aghajanian, 2014, Gynecologic oncology.

Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer.

B. Goff, C. Aghajanian, S. Blank, 2015, Gynecologic oncology.

Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab (BV) plus chemotherapy (CT) for platinum (PT)-resistant recurrent ovarian cancer (OC).

P. Vuylsteke, E. Pujade-Lauraine, A. Husain, 2014 .

MERiDiAN: A phase III, randomized, double-blind study of the efficacy, safety, and associated biomarkers of bevacizumab plus paclitaxel compared with paclitaxel plus placebo, as first-line treatment of patients with HER2-negative metastatic breast cancer.

D. Miles, J. O’Shaughnessy, L. Faoro, 2013 .